Testing effectiveness (Phase 2)UnknownNCT03321123
What this trial is testing
MB-CART19.1 in Patients With R/R ALL
Who this might be right for
Precursor B-Lymphoblastic Lymphoma/Leukaemia Refractory
Shanghai Children's Medical Center 10
Showing 20 of 0 results